Genomic Vision Logo

Genomic Vision

Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.

GV | PA

Overview

Corporate Details

ISIN(s):
FR0011799907
LEI:
969500UXJNBY1C8Y8471
Country:
France
Address:
80 RUE DES MEUNIERS, 92220 BAGNEUX
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genomic Vision is a biotechnology company that develops advanced tools, services, and diagnostic solutions for genetic analysis. The company specializes in visualizing and characterizing individual DNA molecules through its proprietary Molecular Combing Technology, a nanotechnology platform for highly accurate DNA analysis. Its products and services are utilized in the research and diagnosis of cancer and inherited genetic diseases, as well as in drug discovery and biomanufacturing for cell characterization. Genomic Vision aims to establish new standards for DNA analysis to improve disease monitoring and treatment strategies.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-17 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 171.1 KB
2023-11-17 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 168.7 KB
2023-11-14 18:00
Legal Proceedings Report
Inside Information / News release on accounts, results
English 183.9 KB
2023-11-14 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 182.8 KB
2023-11-08 18:38
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 79.6 KB
2023-11-07 18:00
Board/Management Information
Informations privilégiées / Autres communiqués
French 165.9 KB
2023-11-03 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 133.1 KB
2023-11-03 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 134.9 KB
2023-11-02 07:00
Earnings Release
Informations privilégiées / Autres communiqués
French 166.5 KB
2023-11-02 07:00
Environmental & Social Information
Inside Information / Other news releases
English 165.6 KB
2023-10-24 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 123.8 KB
2023-10-24 18:00
Regulatory News Service
Inside Information / Other news releases
English 122.3 KB
2023-10-19 09:29
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 272.4 KB
2023-10-18 14:49
Major Shareholding Notification
Franchissement de seuils
French 272.6 KB
2023-10-12 07:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 157.0 KB

Automate Your Workflow. Get a real-time feed of all Genomic Vision filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genomic Vision via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.